iMcKesson, the e-health business launched with much fanfare by McKesson/HBOC less than a year ago, has met with a swift end. McKesson/HBOC plans to fold the unit’s physician and transaction processing services into its information technologies
iMcKesson, the e-health business launched with much fanfare by McKesson/HBOC less than a year ago, has met with a swift end. McKesson/HBOC plans to fold the unit’s physician and transaction processing services into its information technologies division and drop the iMcKesson name. The company attributes the sudden restructuring to changes in market conditions. iMcKesson CEO David Mahoney, who was also co-CEO of McKesson/HBOC, plans to leave the company. John Hammergren, chair of the board, is now president and CEO of McKesson/HBOC. iMcKesson lost $124 million in the first nine months of the current fiscal year, although $95 million of that was attributed to write-offs on investments such as WebMD.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.